GPER in metabolic homeostasis and disease: molecular mechanisms, nutritional regulation, and therapeutic potential
Open accessThe DOI matches its Crossref record; 286 of the 286 references it cites were found in a registry or an index.
Abstract
G protein-coupled estrogen receptor (GPER) significantly influences metabolic regulation by engaging multiple signaling pathways that affect overall metabolic health. Its structure and signaling mechanisms drive its diverse roles. Our team and others have successfully demonstrated that GPER modulates nutrient metabolism, spanning glucose, protein, and lipid metabolism, while also contributing to vitamin and mineral metabolism. Studies have linked GPER to metabolic disorders, including type 2 diabetes, nonalcoholic fatty liver disease, metabolic syndrome, and cardiovascular diseases, as well as thyroid disorders, highlighting its wide-reaching metabolic impact. GPER holds promise for energy balance and weight management by regulating energy expenditure and thermogenesis. Moreover, it appears to influence the metabolism of cancer cells during tumor progression. Rapid advancements in GPER agonist and antagonist research have highlighted the therapeutic potential of GPER agonists for treating metabolic diseases. Further investigations into GPER biology, mechanisms, and clinical applications will support novel therapeutic strategies, establishing GPER as a key target in metabolic research and treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Many of the beneficial effects of E2 on energy metabolism are increasingly being attributed to its interaction with GPER1, including its rapid effects on insulin sensitivity, hepatic glucose and lipid metabolism (132, 133).”
From Metabolic impact of endogenously produced estrogens by adipose tissue in females and males across the lifespan (2025) · cites this paper as [133]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The metabolic benefits of E2 have been well studied, with evidence that it promotes insulin-sensitivity and improved lipid metabolism in tandem with estrogen receptors, primarily ERα (90) and GPER1 (133).”
From Metabolic impact of endogenously produced estrogens by adipose tissue in females and males across the lifespan (2025) · cites this paper as [133]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Yang, H., Wang, C., Liao, H., & Wang, Q. (2021) · Oncology Letters · doi:10.3892/ol.2021.12693 · Cited by 31
RetractedRepertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1
Kim, J., Kundu, M., Viollet, B., & Guan, K.-L. (2011) · Nature Cell Biology · doi:10.1038/ncb2152 · Cited by 7,227 · cited 1×
“It also induces autophagy to support cell survival, regulating enzymes such as ACC and HMGCR (3-hydroxy-3-methylglutaryl-CoA reductase) to limit adipocyte processes [64, 65].”
Cui, C., Cui, J., Jin, F., Cui, Y., Li, R., Jiang, X., Tian, Y., Wang, K., Jiang, P., & Gao, J. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479571 · Cited by 5,203
AMPK: guardian of metabolism and mitochondrial homeostasis
Herzig, S., & Shaw, R. J. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.95 · Cited by 4,061
AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy
Hardie, D. G. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2249 · Cited by 2,216 · cited 1×
“AMPK inhibits fatty acid synthesis via acetyl-CoA carboxylase (ACC) phosphorylation and promotes glucose uptake by facilitating glucose transport protein 4 (GLUT4) translocation [62, 63], increasing insulin secretion [64].”
The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030
Vogel, B., Acevedo, M., Appelman, Y., Bairey Merz, C. N., Chieffo, A., Figtree, G. A., Guerrero, M., Kunadian, V., Lam, C. S. P., Maas, A. H. E. M., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00684-x · Cited by 1,488
Identity of an Estrogen Membrane Receptor Coupled to a G Protein in Human Breast Cancer Cells
Thomas, P., Pang, Y., Filardo, E. J., & Dong, J. (2005) · Endocrinology · doi:10.1210/en.2004-1064 · Cited by 1,407 · cited 1×
“Upon ligand binding, GPER activates Gαs, stimulating adenylyl cyclase (AC) to increase intracellular cAMP levels [27].”
Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease
Ngo, V., & Duennwald, M. L. (2022) · Antioxidants · doi:10.3390/antiox11122345 · Cited by 1,130 · cited 1×
“The activation of GPER has been reported to stimulate the nuclear factor erythroid 2-related factor 2 (Nrf2) pathway [121, 122], resulting in the upregulation of the expression of antioxidant enzymes, including superoxide dismutase (SOD) and glutathione peroxidase (GPx) [123].”
The G-protein-coupled estrogen receptor GPER in health and disease
Prossnitz, E. R., & Barton, M. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.122 · Cited by 925 · cited 1×
“This activation also improves metabolic health, reduces adiposity, and increases insulin sensitivity [85].”
Chronic Low Grade Inflammation in Pathogenesis of PCOS
Rudnicka, E., Suchta, K., Grymowicz, M., Calik-Ksepka, A., Smolarczyk, K., Duszewska, A. M., Smolarczyk, R., & Meczekalski, B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073789 · Cited by 680 · cited 1×
“Studies have shown that the levels of various inflammatory markers, including C-reactive protein (CRP), IL-6 and TNF-α, which are closely associated with metabolic dysfunction and reproductive impairment, are elevated in PCOS patients [160, 161].”
Role of vitamin E as a lipid-soluble peroxyl radical scavenger: in vitro and in vivo evidence
Niki, E. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.03.022 · Cited by 670 · cited 1×
“Vitamin E, predominantly in the form of α-tocopherol, serves as a critical lipid-soluble antioxidant that safe-guards cell membranes against oxidative damage by neutralizing free radicals [120].”
Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma
Du, D., Liu, C., Qin, M., Zhang, X., Xi, T., Yuan, S., Hao, H., & Xiong, J. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.09.019 · Cited by 643 · cited 1×
“G1 promotes cell proliferation and survival while increasing insulin sensitivity and attenuating inflammatory responses, underscoring its therapeutic potential for metabolic disorders [251, 252].”
Self-citationIn vivo effects of a GPR30 antagonist
Dennis, M. K., Burai, R., Ramesh, C., Petrie, W. K., Alcon, S. N., Nayak, T. K., Bologa, C. G., Leitao, A., Brailoiu, E., Deliu, E., et al. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.168 · Cited by 532 · cited 1×
“GPER, initially called G protein-coupled receptor 30 (GPR30) in the 1990 s [9, 10], mediates the nongenomic effects of 17β-estradiol via mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase 1/2 (ERK-1/2).”
Role of Estrogens in the Regulation of Liver Lipid Metabolism
Palmisano, B. T., Zhu, L., & Stafford, J. M. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-70178-3_12 · Cited by 527 · cited 1×
“Interestingly, sex differences further highlight the role of GPER, with females exhibiting superior fatty acid metabolism, likely due to estrogen and its receptors [102, 103].”
Transcriptional Regulation of the Warburg Effect in Cancer by SIX1
Li, L., Liang, Y., Kang, L., Liu, Y., Gao, S., Chen, S., Li, Y., You, W., Dong, Q., Hong, T., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.01.010 · Cited by 407 · cited 1×
“The “Warburg effect” refers to the phenomenon in which tumor cells enhance glycolytic pathways to obtain energy under hypoxic conditions [228, 229].”
Self-citationA Basic Review on Estrogen Receptor Signaling Pathways in Breast Cancer
Clusan, L., Ferrière, F., Flouriot, G., & Pakdel, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076834 · Cited by 382 · cited 1×
“It was initially identified as the third ER [11].”
27-Hydroxycholesterol Promotes Cell-Autonomous, ER-Positive Breast Cancer Growth
Wu, Q., Ishikawa, T., Sirianni, R., Tang, H., McDonald, J. G., Yuhanna, I. S., Thompson, B., Girard, L., Mineo, C., Brekken, R. A., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.10.006 · Cited by 358 · cited 1×
“Selective GPER agonists have exhibited high specificity and potent biological activity in preclinical studies [249].”
Bord, S., Ireland, D. C., Beavan, S. R., & Compston, J. E. (2003) · Bone · doi:10.1016/s8756-3282(02)00953-5 · Cited by 333 · cited 1×
“Additionally, it may promote the expression of OPG while inhibiting the formation and activity of osteoclasts, consequently lowering the rate of bone resorption and assisting in maintaining bone density and quality [142].”
Identification of a GPER/GPR30 antagonist with improved estrogen receptor counterselectivity
Dennis, M. K., Field, A. S., Burai, R., Ramesh, C., Petrie, W. K., Bologa, C. G., Oprea, T. I., Yamaguchi, Y., Hayashi, S.-I., Sklar, L. A., et al. (2011) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2011.07.002 · Cited by 311 · cited 1×
“GPER antagonists primarily include small-molecule compounds, among which G15 and G36 are two representative antagonists [276, 277].”
Genetic Liver-Specific AMPK Activation Protects against Diet-Induced Obesity and NAFLD
Garcia, D., Hellberg, K., Chaix, A., Wallace, M., Herzig, S., Badur, M. G., Lin, T., Shokhirev, M. N., Pinto, A. F. M., Ross, D. S., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2018.12.036 · Cited by 293 · cited 1×
“In animal models, AMPK activation mitigates high-fat diet-induced metabolic disorders, promoting fatty acid oxidation and glucose metabolism in obese individuals while reducing fat accumulation [66].”
The G protein-coupled oestrogen receptor GPER in health and disease: an update
Prossnitz, E. R., & Barton, M. (2023) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00822-7 · Cited by 231
Role of Estrogen in Thyroid Function and Growth Regulation
Santin, A. P., & Furlanetto, T. W. (2011) · Journal of Thyroid Research · doi:10.4061/2011/875125 · Cited by 224 · cited 1×
“GPER may also modulate the thyroid-stimulating hormone (TSH) signaling pathway, directly impacting the effects of TSH on thyroid function and influencing thyroid hormone synthesis and secretion [207–209].”
Sharma, G., Hu, C., Brigman, J. L., Zhu, G., Hathaway, H. J., & Prossnitz, E. R. (2013) · Endocrinology · doi:10.1210/en.2013-1357 · Cited by 210 · cited 2×
“In vivo models have shown that G1 significantly alleviates obesity and metabolic disturbances by limiting weight gain, reducing insulin resistance and inflammation, and improving glucose and lipid homeostasis [174].”
Mitochondrial Dysfunction and Chronic Inflammation in Polycystic Ovary Syndrome
Dabravolski, S. A., Nikiforov, N. G., Eid, A. H., Nedosugova, L. V., Starodubova, A. V., Popkova, T. V., Bezsonov, E. E., & Orekhov, A. N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22083923 · Cited by 207 · cited 2×
“Chronic inflammation not only affects ovarian function but also exacerbates the symptoms of PCOS by influencing insulin resistance and lipid metabolism, creating a vicious cycle [155, 160].”
Intestinal Vitamin D Receptor Is Required for Normal Calcium and Bone Metabolism in Mice
Xue, Y., & Fleet, J. C. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.12.051 · Cited by 202 · cited 2×
“Vitamin D receptor (VDR) plays a critical role in vitamin D metabolism [104].”
Kolczynska, K., Loza-Valdes, A., Hawro, I., & Sumara, G. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01286-8 · Cited by 199 · cited 1×
“Moreover, DAG activates protein kinase C (PKC) to regulate metabolic enzymes and downstream signaling [44, 45].”
The RANK–RANKL–OPG System: A Multifaceted Regulator of Homeostasis, Immunity, and Cancer
León-Oliva, D. D., Barrena-Blázquez, S., Jiménez-Álvarez, L., Fraile‐Μartinez, O., Montero, C. G., López-González, L., Torres‐Carranza, D., García-Puente, L. M., Carranza, S. T., Álvarez-Mon, M. Á., et al. (2023) · Medicina · doi:10.3390/medicina59101752 · Cited by 192
Metabolic reprogramming in osteoclasts
Park-Min, K.-H. (2019) · Seminars in Immunopathology · doi:10.1007/s00281-019-00757-0 · Cited by 191 · cited 1×
“In tumor cells, certain metabolic processes change due to their survival and proliferation needs, a process known as “tumor metabolic reprogramming“ [223–225].”
Zhou, D., Duan, Z., Li, Z., Ge, F., Wei, R., & Kong, L. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1091779 · Cited by 181 · cited 1×
“Moreover, TNF-α can promote glycolysis through the activation of the NF-κB signaling pathway, supporting rapid tumor cell proliferation by inducing metabolic reprogramming in the tumor micro-environment [234, 237] and thereby enhancing the adaptive growth and metastatic capabilities of tumor cells.”
Tiano, J. P., Delghingaro-Augusto, V., Le May, C., Liu, S., Kaw, M. K., Khuder, S. S., Latour, M. G., Bhatt, S. A., Korach, K. S., Najjar, S. M., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44564 · Cited by 180 · cited 1×
“GPER also inhibits lipogenesis by suppressing key enzymes, including fatty acid synthase (FASN) and SREBP-1c SREBP-1c [ 81, 92, 93 ].”
The effects of metformin on autophagy
Lu, G., Wu, Z., Shang, J., Xie, Z., Chen, C., & zhang, C. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111286 · Cited by 173 · cited 1×
“Additionally, the GPER/AMPK interplay may improve insulin signaling and resistance [68].”
Adipokines: inflammation and the pleiotropic role of white adipose tissue
Trayhurn, P. (2022) · British Journal Of Nutrition · doi:10.1017/s0007114521003962 · Cited by 169 · cited 1×
“BAT, distinguished by its high mitochondrial density and extensive vascularization, dissipates energy by nonshivering thermogenesis, whereas WAT primarily serves as an energy storage depot and secretes a variety of metabolic hormones and cytokines [210].”
G Protein-Coupled Estrogen Receptor-Selective Ligands Modulate Endometrial Tumor Growth
Petrie, W. K., Dennis, M. K., Hu, C., Dai, D., Arterburn, J. B., Smith, H. O., Hathaway, H. J., & Prossnitz, E. R. (2013) · Obstetrics and Gynecology International · doi:10.1155/2013/472720 · Cited by 166 · cited 1×
“In endometrial cancer cells, fulvestrant upregulates the genes Cyclin D1 and CDK4 through GPER activation, driving the cell cycle transition from G1 phase to S phase, indicating its role as a GPER agonist [270–272].”
The Concise Guide to PHARMACOLOGY 2023/24: Transporters
Alexander, S. P. H., Fabbro, D., Kelly, E., Mathie, A. A., Peters, J. A., Veale, E. L., Armstrong, J. F., Faccenda, E., Harding, S. D., Davies, J. A., et al. (2023) · British Journal of Pharmacology · doi:10.1111/bph.16182 · Cited by 163
The pathophysiology of visceral adipose tissues in cardiometabolic diseases
Lee, M., & Kim, J. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116116 · Cited by 162 · cited 1×
“Vis-ceral fat, which surrounds internal organs, has metabolic properties distinct from those of subcutaneous fat, and excess visceral fat increases the risk of metabolic diseases [179].”
Yu, T., Yang, G., Hou, Y., Tang, X., Wu, C., Wu, X.-A., Guo, L., Zhu, Q., Luo, H., Du, Y.-E., et al. (2016) · Oncogene · doi:10.1038/onc.2016.370 · Cited by 153 · cited 5×
“G15, a widely used selective GPER antagonist, Preclinical research [261] has been shown to effectively inhibit GPER-mediated biological responses in various cellular models [227].”
InfluentialSelf-citationThe Role of JNk Signaling Pathway in Obesity-Driven Insulin Resistance
Feng, J., Lu, S., Ou, B., Liu, Q., Dai, J., Ji, C., Zhou, H., Huang, H., & Ma, Y. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s236127 · Cited by 151 · cited 1×
“Aberrant MAPK activation is implicated in insulin resistance in metabolic disorders such as obesity and type 2 mellitus [55, 56].”
Estriol acts as a GPR30 antagonist in estrogen receptor-negative breast cancer cells
Lappano, R., Rosano, C., Marco, P. D., Francesco, E. M. D., Pezzi, V., & Maggiolini, M. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.02.006 · Cited by 137 · cited 1×
“Furthermore, the development of novel GPER antagonists is continually advancing [281, 282].”
The Role of ERK1/2 in the Development of Diabetic Cardiomyopathy
Xu, Z., Sun, J., Tong, Q., Lin, Q., Qian, L.-B., Park, Y., & Zheng, Y. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17122001 · Cited by 137
G Protein–Coupled Estrogen Receptor GPER: Molecular Pharmacology and Therapeutic Applications
Arterburn, J. B., & Prossnitz, E. R. (2023) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-031122-121944 · Cited by 137 · cited 2×
“Mechanis-tically, GPER activates the PI3K/AKT signaling pathway to regulate insulin sensitivity, and it activates intracellular calcium signaling through Gq-mediated phospholipase C activation [3, 42].”
GPCR signalling from within the cell
Jong, Y.-J. I., Harmon, S. K., & O’Malley, K. L. (2017) · British Journal of Pharmacology · doi:10.1111/bph.14023 · Cited by 136 · cited 1×
“These domains form a ligand-binding pocket within the cell membrane, enabling the transmission of extracellular signals to trigger intracellular responses [13].”
GPR30 as an initiator of tamoxifen resistance in hormone-dependent breast cancer
Mo, Z., Liu, M., Yang, F., Luo, H., Li, Z., Tu, G., & Yang, G. (2013) · Breast Cancer Research · doi:10.1186/bcr3581 · Cited by 134 · cited 1×
“However, they may promote cell proliferation in certain cell types while inducing apoptosis in others [259, 260].”
Roles of G protein-coupled estrogen receptor GPER in metabolic regulation
Sharma, G., Mauvais-Jarvis, F., & Prossnitz, E. R. (2018) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2017.02.012 · Cited by 131 · cited 4×
“Notably, GPER has sex-specific effects: in female animal models, it markedly increases insulin sensitivity, whereas in males, it primarily curbs weight gain and increases glucose tolerance [79].”
InfluentialThe significant role of amino acid metabolic reprogramming in cancer
Liu, X., Ren, B., Ren, J., Gu, M., You, L., & Zhao, Y. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01760-1 · Cited by 126 · cited 1×
“Efficient amino acid metabolism is critical for sustaining physiological homeostasis [83, 84].”
Estrogen Receptors in Polycystic Ovary Syndrome
Xu, X.-L., Deng, S., Lian, Z., & Yu, K. (2021) · Cells · doi:10.3390/cells10020459 · Cited by 116 · cited 4×
“The potential role of GPER in PCOS primarily manifests in its regulation of metabolic and reproductive functions [156].”
InfluentialSelf-citationEstrogen Biosynthesis and Signal Transduction in Ovarian Disease
Xu, X.-L., Huang, Z., Yu, K., Li, J., Fu, X., & Deng, S. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.827032 · Cited by 111 · cited 3×
“In recent years, numerous studies have focused on the role of GPER in PCOS, suggesting that GPER plays a significant role in the pathogenesis of this condition [154, 155].”
Self-citationG protein-coupled estrogen receptor in immune cells and its role in immune-related diseases
Notas, G., Kampa, M., & Castanas, E. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.579420 · Cited by 109 · cited 2×
“…inflammation is recognized as a key factor in inducing insulin resistance, and GPER can modulate intracellular signaling pathways or suppress the expression of proinflammatory cytokines, which reduces the interference of chronic inflammatory responses and improves insulin resistance [1, 34].”
G Protein-Coupled Estrogen Receptor: A Potential Therapeutic Target in Cancer
Xu, S., Yu, S., Dong, D., & Lee, L. T. O. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00725 · Cited by 107 · cited 1×
“This structure enables GPER to interact with diverse endogenous and exogenous ligands, modulating physiological and metabolic processes [15, 16].”
Lipid Droplet–Mitochondria Contacts in Health and Disease
Fan, H., & Tan, Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25136878 · Cited by 107
Preclinical efficacy of the GPER-selective agonist G-1 in mouse models of obesity and diabetes
Sharma, G., Hu, C., Staquicini, D. I., Brigman, J. L., Liu, M., Mauvais-Jarvis, F., Pasqualini, R., Arap, W., Arterburn, J. B., Hathaway, H. J., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aau5956 · Cited by 105 · cited 10×
“In high-fat diet-induced obesity models, the GPER agonist G1 reduces body weight and improves insulin sensitivity, highlighting its endocrine-mediated metabolic role [31, 74].”
InfluentialSantolla, M. F., Lappano, R., De Marco, P., Pupo, M., Vivacqua, A., Sisci, D., Abonante, S., Iacopetta, D., Cappello, A. R., Dolce, V., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.417303 · Cited by 104 · cited 2×
“In addition to its role in protein metabolism, GPER regulates fatty acid metabolism and the cell cycle, potentially modulating amino acid synthesis and degradation to protect cells from metabolic stress and maintain protein balance [3, 86].”
Cheng, S., Dong, J., Pang, Y., LaRocca, J. L., Hixon, M. L., Thomas, P., & Filardo, E. J. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.11.005 · Cited by 104 · cited 1×
“In the kidneys, GPER expression is closely related to the reabsorption and excretion of calcium, and studies have shown that GPER activation can promote the reabsorption of calcium in renal tubules, thus maintaining blood calcium levels [134].”
Non-Alcoholic Fatty Liver Disease: From Pathogenesis to Clinical Impact
Caturano, A., Acierno, C., Nevola, R., Pafundi, P. C., Galiero, R., Rinaldi, L., Salvatore, T., Adinolfi, L. E., & Sasso, F. C. (2021) · Processes · doi:10.3390/pr9010135 · Cited by 104 · cited 1×
“Closely linked to metabolic syndrome, NAFLD involves intricate pathological mechanisms, including dysregulated lipid metabolism, insulin resistance, oxidative stress, and inflammation [165–167].”
Davis, K. E., Carstens, E. J., Irani, B. G., Gent, L. M., Hahner, L. M., & Clegg, D. J. (2014) · Hormones and Behavior · doi:10.1016/j.yhbeh.2014.02.004 · Cited by 103 · cited 1×
“Studies have shown that the expression of the thermogenic gene UCP1 is decreased in the BAT of GPER knockout (KO) mice [213].”
Overarching roles of diacylglycerol signaling in cancer development and antitumor immunity
Cooke, M., & Kazanietz, M. G. (2022) · Science Signaling · doi:10.1126/scisignal.abo0264 · Cited by 103 · cited 1×
“IP3, a key second messenger, binds endoplasmic reticulum receptors to rapidly mobilize calcium, modulating excitability and metabolism [41–43].”
G-Protein Coupled Estrogen Receptor in Breast Cancer
Hsu, L.-H., Chu, N.-M., Lin, Y.-F., & Kao, S.-H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020306 · Cited by 102 · cited 1×
“These transcription factors regulate the expression of GPER target genes, ultimately promoting the apoptosis of cancer cells [69, 70].”
Liu, X., Zhang, Z., Song, Y., Xie, H., & Dong, M. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1065263 · Cited by 102 · cited 1×
“For example, GPER enhances adipocyte energy metabolism by regulating the expression of β-adrenergic receptors and other metabolism-associated genes [215].”
Ford, J., Hajibeigi, A., Long, M., Hahner, L., Gore, C., Hsieh, J.-T., Clegg, D., Zerwekh, J., & Öz, O. K. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.209 · Cited by 100 · cited 1×
“In osteoblasts lacking classical ERα and ERβ, the expression and activation of GPER can mediate the biological effects of estrogen, demonstrating its key role in bone metabolism [143, 147].”
The role of GPCRs in bone diseases and dysfunctions
Luo, J., Sun, P., Siwko, S., Liu, M., & Xiao, J. (2019) · Bone Research · doi:10.1038/s41413-019-0059-6 · Cited by 99 · cited 3×
“GPER activation also modulates intracellular calcium dynamics, triggering rapid calcium release, which may be crucial for the function and survival of various bone components [131].”
InfluentialDual Effects of Lipid Metabolism on Osteoblast Function
Alekos, N. S., Moorer, M. C., & Riddle, R. C. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.578194 · Cited by 95
Inflammation and Cardiovascular Disease: The Future
Arnold, N., Lechner, K., Waldeyer, C., Shapiro, M. D., & Köenig, W. (2021) · European Cardiology Review · doi:10.15420/ecr.2020.50 · Cited by 95 · cited 2×
“Chronic inflammation, a critical driver of CVDs, including atherosclerosis and heart failure [201], promotes immune cell recruitment and endothelial dysfunction [186].”
MIBE acts as antagonist ligand of both estrogen receptor α and GPER in breast cancer cells
Lappano, R., Santolla, M. F., Pupo, M., Sinicropi, M. S., Caruso, A., Rosano, C., & Maggiolini, M. (2012) · Breast Cancer Research · doi:10.1186/bcr3096 · Cited by 94 · cited 1×
“3-[5-(2-Ethyl carbonyl-1-methylvinoxy)−1-methyl-1 H-indol-3-yl]but-2-enoic acid ethyl ester, referred to as MIBE, is a synthetic compound that exhibits dual antagonism of ERα and GPER by blocking GPER-mediated transactivation of EGFR and inhibiting ERK phosphorylation [279].”
He, W., Gao, Z., Liu, S., Tan, L., Wu, Y., Liu, J., Zheng, Z., Fan, W., Luo, Y., Chen, Z., et al. (2023) · Environmental Pollution · doi:10.1016/j.envpol.2023.122211 · Cited by 90 · cited 2×
“Chronic low-grade inflammation in adipose tissue is a critical driver of MS, and GPER activation attenuates this inflammation, promoting fatty acid oxidation and energy metabolism [133, 175].”
Self-citationG-Protein-Coupled Estrogen Receptor (GPER) and Sex-Specific Metabolic Homeostasis
Sharma, G., & Prossnitz, E. R. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-70178-3_20 · Cited by 88 · cited 2×
“Interestingly, sex differences further highlight the role of GPER, with females exhibiting superior fatty acid metabolism, likely due to estrogen and its receptors [102, 103].”
Elder, P., Sharma, G., Gulati, M., & Michos, E. D. (2020) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2020.100028 · Cited by 87
Yu, T., Liu, M., Luo, H., Wu, C., Tang, X., Tang, S., Hu, P., Yan, Y., Wang, Z., & Tu, G. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.05.003 · Cited by 84 · cited 1×
“…fibroblasts (CAFs) within triple-negative breast cancer mediates the synthesis and secretion of lactic acid and glutamine, exacerbating the metabolic remodeling of breast cancer and leading to multidrug resistance in tumor cells [227, 243], a process known as the “reverse Warburg effect”.”
Self-citationRetinoids in the visual cycle: role of the retinal G protein-coupled receptor
Choi, E. H., Daruwalla, A., Suh, S., Leinonen, H., & Palczewski, K. (2020) · Journal of Lipid Research · doi:10.1194/jlr.tr120000850 · Cited by 84 · cited 1×
“Moreover, GPER activation has been shown to improve retinal structure and function, which can help mitigate visual impairments associated with vitamin A deficiency [117–119], involving the potential mechanism of regulating retinal neuron survival via oxidative damage and apoptosis.”
Two Novel GPER Agonists Induce Gene Expression Changes and Growth Effects in Cancer Cells
Lappano, R., Rosano, C., Santolla, M. F., Pupo, M., Francesco, E. M. D., Marco, P. D., Ponassi, M., Spallarossa, A., Ranise, A., & Maggiolini, M. (2012) · Current Cancer Drug Targets · doi:10.2174/156800912800673284 · Cited by 80 · cited 2×
“G15, a widely used selective GPER antagonist, Preclinical research [261] has been shown to effectively inhibit GPER-mediated biological responses in various cellular models [227].”
The G protein-coupled estrogen receptor as a modulator of neoplastic transformation
Jacenik, D., Cygankiewicz, A. I., & Krajewska, W. M. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.04.011 · Cited by 80 · cited 1×
“The latter inhibits STAT3 phosphorylation via GPER, reducing the secretion of inflammatory factors and suppressing the reprogramming of the tumor microenvironment [269].”
GPER is a mechanoregulator of pancreatic stellate cells and the tumor microenvironment
Cortes, E., Sarper, M., Robinson, B., Lachowski, D., Chronopoulos, A., Thorpe, S. D., Lee, D. A., & del Río Hernández, A. E. (2019) · EMBO reports · doi:10.15252/embr.201846556 · Cited by 78 · cited 2×
“Additionally, GPER influences macrophage polarization, promoting the proliferation of anti-inflammatory M2 macrophages, which helps suppress obesity-related inflammation [180, 182, 183].”
Wei, T., Chen, W., Wen, L., Zhang, J., Zhang, Q., Yang, J., Liu, H., Chen, B. W., Zhou, Y., Feng, X., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.08.012 · Cited by 76 · cited 1×
“More-over, GPER activation is associated with the enhancement of anti-inflammatory signaling pathways in the liver, further supporting its potential application in the prevention and treatment of NAFLD [172].”
Self-citationLiver Fibrosis and MAFLD: From Molecular Aspects to Novel Pharmacological Strategies
Qu, W., Ma, T., Cai, J., Zhang, X., Zhang, P., She, Z., Wan, F., & Li, H. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.761538 · Cited by 76 · cited 1×
“In both in vivo and in vitro models, G1 significantly improves metabolic parameters linked to metabolic diseases [254].”
Self-citationRigiracciolo, D. C., Scarpelli, A., Lappano, R., Pisano, A., Santolla, M. F., Avino, S., De Marco, P., Bussolati, B., Maggiolini, M., & De Francesco, E. M. (2016) · Oncotarget · doi:10.18632/oncotarget.6475 · Cited by 70 · cited 1×
“An acidic environment may activate GPER signaling by affecting the cell membrane potential and ion channel activity, thereby enhancing the metabolic adaptability and survival capacity of tumor cells [232, 233].”
Ishii, T., & Warabi, E. (2019) · Antioxidants · doi:10.3390/antiox8030069 · Cited by 70 · cited 1×
“The activation of GPER has been reported to stimulate the nuclear factor erythroid 2-related factor 2 (Nrf2) pathway [121, 122], resulting in the upregulation of the expression of antioxidant enzymes, including superoxide dismutase (SOD) and glutathione peroxidase (GPx) [123].”
Liu, Q., Liu, Y., Li, X., Wang, D., Zhang, A., Pang, J., He, J., Chen, X., & Tang, N. (2022) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2023.114980 · Cited by 68 · cited 1×
“Moreover, GPER activates several cellular signaling pathways, including the PI3K/AKT and MAPK pathways, which are integral to various metabolic processes [127].”
Chuang, S., Chen, C., Chou, Y., Ho, M., & Chang, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186490 · Cited by 67 · cited 1×
“G protein-coupled estrogen receptor (GPER), a novel estrogen receptor, is widely expressed across various cells and tissues and regulates diverse physiological and pathological processes [1, 2].”
From physiology to pathology: Emerging roles of GPER in cardiovascular disease
Wang, Z., Liu, J., Chen, Y., Tang, Y., Chen, T., Zhou, C. S., Wang, S., Chang, R., Chen, Z., Yang, W., et al. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108801 · Cited by 67 · cited 2×
“In hypertension, GPER regulates vascular smooth muscle function through signaling pathways, influencing blood pressure and vascular contractility [176].”
Self-citationBian, C., Bai, B., Gao, Q., Li, S., & Zhao, Y. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00531 · Cited by 66 · cited 6×
“Unlike classical estrogen receptors α and β (ERα and ERβ), GPER mediates rapid nongenomic estrogen signaling and influences ER-negative diseases [3].”
InfluentialWang, K., Zheng, X., Pan, Z., Yao, W., Gao, X. Y., Wang, X., & Ding, X. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00559 · Cited by 65 · cited 1×
“The activation of GPER has been reported to stimulate the nuclear factor erythroid 2-related factor 2 (Nrf2) pathway [121, 122], resulting in the upregulation of the expression of antioxidant enzymes, including superoxide dismutase (SOD) and glutathione peroxidase (GPx) [123].”
Cao, Y., Zhao, L.-W., Chen, Z.-X., & Li, S.-H. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1430465 · Cited by 65 · cited 1×
“G1 has also been found to improve symptoms of obesity and related metabolic syndromes by regulating lipid and glucose metabolism [253].”
Impairments in remote memory caused by the lack of Type 2 IP3 receptors
Pinto‐Duarte, A., Roberts, A. J., Ouyang, K., & Sejnowski, T. J. (2019) · Glia · doi:10.1002/glia.23679 · Cited by 64
GPER mediates the effects of 17β-estradiol in cardiac mitochondrial biogenesis and function
Sbert-Roig, M., Bauzá-Thorbrügge, M., Galmés-Pascual, B. M., Capllonch-Amer, G., García-Palmer, F., Lladó, I., Proenza, A. M., & Gianotti, M. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.11.027 · Cited by 63 · cited 1×
“GPER activation also promotes mitochondrial biogenesis, improves mitochondrial function, and bolsters cellular energy metabolism [4, 216, 217].”
Feng, Y., Tang, Z., & Zhang, W. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115470 · Cited by 63 · cited 1×
“Research has shown that macrophages and T cells in PCOS patients exhibit dysfunction and a chronic inflammatory state, further inten-sifying the inflammatory response and affecting ovarian function [162].”
Aiello, F., Carullo, G., Giordano, F., Spina, E., Nigro, A., Garofalo, A., Tassini, S., Costantino, G., Vincetti, P., Bruno, A., et al. (2017) · ChemMedChem · doi:10.1002/cmdc.201700145 · Cited by 62
Liu, C., Liao, Y., Fan, S., Fu, X., Xiong, J., Zhou, S., Zou, M., & Wang, J. (2017) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504017x15035795904677 · Cited by 62 · cited 1×
“GPER antagonists primarily include small-molecule compounds, among which G15 and G36 are two representative antagonists [276, 277].”
Uric Acid and Arterial Stiffness
Albu, A., Para, I., & Porojan, M. D. (2020) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s232033 · Cited by 61 · cited 1×
“Hyperuricemia, which is closely associated with MS, exacerbates hypertension by promoting inflammatory responses and oxidative stress [177].”
Intrathyroidal feedforward and feedback network regulating thyroid hormone synthesis and secretion
Jing, L., & Zhang, Q. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.992883 · Cited by 61 · cited 1×
“GPER may also modulate the thyroid-stimulating hormone (TSH) signaling pathway, directly impacting the effects of TSH on thyroid function and influencing thyroid hormone synthesis and secretion [207–209].”
Self-citationThe Role of G Protein-Coupled Estrogen Receptor (GPER) in Vascular Pathology and Physiology
Xu, F., Ma, J., Wang, X., Wang, X., Fang, W., Sun, J., Li, Z., & Liu, J. (2023) · Biomolecules · doi:10.3390/biom13091410 · Cited by 61 · cited 1×
“For example, GPER promotes the phosphorylation of AMPK, enhancing cellular adaptation to energy deficits and improving metabolic efficiency [170, 221, 222].”
Self-citationMandal, S., Bandyopadhyay, S., Tyagi, K., & Roy, A. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188619 · Cited by 59 · cited 1×
“GPER activates the phosphatidylinositol-4,5-bisphos-phate (PIP2) signaling pathway through Gαq [38, 39].”
Molecular Mechanisms of Estrogen Receptors' Suppression of Lipogenesis in Pancreatic β-Cells
Tiano, J. P., & Mauvais-Jarvis, F. (2012) · Endocrinology · doi:10.1210/en.2011-1980 · Cited by 57 · cited 1×
“GPER also inhibits lipogenesis by suppressing key enzymes, including fatty acid synthase (FASN) and SREBP-1c SREBP-1c [ 81, 92, 93 ].”
Pepermans, R. A., Sharma, G., & Prossnitz, E. R. (2021) · Cells · doi:10.3390/cells10030672 · Cited by 57 · cited 1×
“An acidic environment may activate GPER signaling by affecting the cell membrane potential and ion channel activity, thereby enhancing the metabolic adaptability and survival capacity of tumor cells [232, 233].”
Current Understanding on the Role of Lipids in Macrophages and Associated Diseases
Florance, I., & Seenivasan, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010589 · Cited by 54 · cited 1×
“It underpins energy balance and cellular functions, with its dysregulation implicated in numerous metabolic disorders [89–91].”
Is It Time to Reconsider the U.S. Recommendations for Dietary Protein and Amino Acid Intake?
Weiler, M., Hertzler, S. R., & Dvoretskiy, S. (2023) · Nutrients · doi:10.3390/nu15040838 · Cited by 54
Hulchiy, M., Nybacka, Å., Sahlin, L., & Hirschberg, A. L. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3803 · Cited by 53 · cited 2×
“High GPER expression may be associated with better ovarian function and a better reproductive prognosis [157], providing a theoretical basis for the use of GPER as a biomarker and therapeutic target for PCOS [154].”
Cruz, A. G., Contreras, C., Sánchez, A., & Prieto, D. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00055 · Cited by 52
Molecular Mechanisms of Tamoxifen Therapy for Cholangiocarcinoma: Role of Calmodulin
Pawar, P., Ma, L., Byon, C. H., Liu, H., Ahn, E.-Y. E., Jhala, N. C., Arnoletti, J. P., McDonald, J. M., & Chen, Y. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1150 · Cited by 51 · cited 1×
“However, they may promote cell proliferation in certain cell types while inducing apoptosis in others [259, 260].”
Mangiamele, L. A., Gomez, J. R., Curtis, N. J., & Thompson, R. R. (2016) · The Journal of Comparative Neurology · doi:10.1002/cne.24056 · Cited by 50 · cited 1×
“Studies indicate that GPER activation increases retinol utilization by retinal cells, thereby improving light sensitivity and visual function [114, 115].”
Non-canonical Estrogen Signaling in Endocrine Resistance
Ranganathan, P., Nadig, N., & Nambiar, S. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00708 · Cited by 48 · cited 1×
“Studies have shown that GPER activation promotes estrogen-dependent tumor cell proliferation through MAPK, linking GPER expression to tumor progression [50].”
Liu, H., Yan, Y., Wen, H., Jiang, X., Cao, X., Zhang, G., & Liu, G. (2014) · Cell Biology International · doi:10.1002/cbin.10243 · Cited by 46
Evidence for G‐Protein–Coupled Estrogen Receptor as a Pronatriuretic Factor
Gohar, E. Y., Daugherty, E. M., Aceves, J. O., Sedaka, R., Obi, I. E., Allan, J. M., Soliman, R. H., Jin, C., Miguel, C. D., Lindsey, S. H., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.015110 · Cited by 46 · cited 1×
“The evidence suggests that GPER may influence uric acid metabolism by regulating renal sodium excretion, potentially exerting protective effects on hyperuricemia [178].”
Llorente, R., Marraudino, M., Carrillo, B., Bonaldo, B., Simon‐Areces, J., Abellanas-Pérez, P., Rivero-Aguilar, M., Fernández‐García, J. M., Pinos, H., García‐Segura, L. M., et al. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00537 · Cited by 45 · cited 1×
“Furthermore, it is also expressed in chondrocytes and is particularly abundant in the growth plate [145].”
Yuan, L.-J., Zhang, M., Chen, S., & Chen, W. (2020) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2020.111053 · Cited by 45
Singh, P., O’Toole, T. E., Conklin, D. J., Hill, B. G., & Haberzettl, P. (2021) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00804.2020 · Cited by 45 · cited 1×
“Endothelial dysfunction, an early indicator of CVDs, is characterized by impaired endothelium-dependent dilation, elevated oxidative stress, and increased inflammation [191].”
Gonzalez, A. L., Dungan, M. M., Smart, C. D., Madhur, M. S., & Doran, A. C. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2023.0284 · Cited by 45 · cited 1×
“Chronic inflammation, a critical driver of CVDs, including atherosclerosis and heart failure [201], promotes immune cell recruitment and endothelial dysfunction [186].”
Ginsenoside Rg1 modulates PI3K/AKT pathway for enhanced osteogenesis via GPER
Jiang, Z., Deng, L., Li, M., Alonge, E., Wang, Y., & Wang, Y. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.155284 · Cited by 45 · cited 2×
“In postmenopausal women, a decrease in estrogen levels impacts the expression of GPER, which significantly increases the risk of osteoporosis [110, 112].”
A calixpyrrole derivative acts as a GPER antagonist: mechanisms and models
Lappano, R., Rosano, C., Pisano, A., Santolla, M. F., Francesco, E. M. D., Marco, P. D., Dolce, V., Ponassi, M., Felli, L., Cafeo, G., et al. (2015) · Disease Models & Mechanisms · doi:10.1242/dmm.021071 · Cited by 44
Farruggio, S., Cocomazzi, G., Marotta, P., Romito, R., Surico, D., Calamita, G., Bellan, M., Pirisi, M., & Grossini, E. (2020) · Cellular Physiology and Biochemistry · doi:10.33594/000000227 · Cited by 44 · cited 2×
“A previous study revealed that genistein can enhance the AMPK signaling pathway and SIRT1 activity through GPER activation, subsequently inhibiting the expression of genes associated with hepatic lipogenesis and further influencing liver metabolic status [169].”
Unravelling Polycystic Ovary Syndrome and Its Comorbidities
Kim, K.-W. (2021) · Journal of Obesity & Metabolic Syndrome · doi:10.7570/jomes21043 · Cited by 44 · cited 1×
“PCOS is a common endocrine disorder that affects women’s reproductive health and is often associated with hormonal imbalances [151], ovarian dysfunction and metabolic abnormalities [152, 153].”
Pham, T. H., Lee, G. H., Jin, S. W., Lee, S. Y., Han, E. H., Kim, N. D., & Jeong, H. G. (2022) · Phytotherapy Research · doi:10.1002/ptr.7526 · Cited by 43 · cited 4×
“Concurrently, GPER is intricately linked to hepatic lipid metabolism, regulating fatty acid oxidation and synthesis to reduce liver inflammation, indirectly influencing glucose metabolism [81].”
InfluentialKhan, S. U., Ahemad, N., Chuah, L., Naidu, R., & Htar, T. T. (2019) · RSC Advances · doi:10.1039/c8ra09318k · Cited by 41 · cited 1×
“…shown that AMPK upregulates fatty acid oxidation genes (e.g., carnitine pal-mitoyl transferase 1 (CPT1) and peroxisome proliferator-activated receptor alpha (PPARα)) and downregulates synthesis genes (e.g., fatty acid synthase (FAS) and sterol regulatory element-binding protein 1c (SREBP-1c)) [67].”
Maggiolini, M., Santolla, M. F., Avino, S., Aiello, F., Rosano, C., Garofalo, A., & Grande, F. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.3 · Cited by 40
GPR119 agonists: Novel therapeutic agents for type 2 diabetes mellitus
Manaithiya, A., Alam, O., Sharma, V., Naim, M. J., Mittal, S., & Khan, I. A. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.104998 · Cited by 39 · cited 1×
“Abbreviations: VDR, vitamin D receptor; PPARα, peroxisome proliferator-activated receptor alpha quality of life and health of hundreds of millions of people [135, 136].”
Tabe, Y., & Konopleva, M. Y. (2023) · Cancer Drug Resistance · doi:10.20517/cdr.2022.133 · Cited by 39 · cited 1×
“…biosynthetic precursors to tumor cells, increasing their metabolic capacity and promoting rapid tumor growth [240]; however, an excessive reliance on fatty acids as an energy source may increase tumor cell sensitivity to specific metabolic inhibitors, thereby restricting tumor cell growth [241].”
A Series of Indole-Thiazole Derivatives Act as GPER Agonists and Inhibit Breast Cancer Cell Growth
O’Dea, A. T., Sondergard, C., Sweeney, P., & Arnatt, C. K. (2018) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.8b00212 · Cited by 38 · cited 1×
“Certain indole–thiazole derivatives were identified as GPER agonists through computer-aided pharmacophore screening and were found to inhibit the growth of breast cancer cells [264].”
Impact of Estrogens on the Regulation of White, Beige, and Brown Adipose Tissue Depots
Bernasochi, G. B., Bell, J. R., Simpson, E. R., Delbridge, L. M. D., & Boon, W. C. (2019) · Comprehensive physiology · doi:10.1002/cphy.c180009 · Cited by 37
Yu, T., Cheng, H., Ding, Z., Wang, Z., Zhou, L., Zhao, P., Tan, S., Xu, X. J., Huang, X., Liu, M., et al. (2020) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2020.110762 · Cited by 37 · cited 2×
“Some nonselective agonists can positively influence obesity and type 2 diabetes by modulating cellular signaling pathways that affect energy metabolism and fat accumulation [257, 258].”
Self-citationEffect of Boswellia species on the metabolic syndrome: A review.
Mahdian, D., Abbaszadeh‐Goudarzi, K., Raoofi, A., Dadashizadeh, G., Abroudi, M., Zarepour, E., & Hosseinzadeh, H. (2020) · PubMed Central · doi:10.22038/ijbms.2020.42115.9957 · Cited by 37 · cited 1×
“MS is a cluster of conditions that negatively impact metabolic health, including obesity, dyslipidemia, hypertension and hyperuricemia [173].”
MicroRNA regulation of AMPK in nonalcoholic fatty liver disease
Sun, H., & Kemper, J. K. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01072-3 · Cited by 37 · cited 1×
“AMPK inhibits fatty acid synthesis via acetyl-CoA carboxylase (ACC) phosphorylation and promotes glucose uptake by facilitating glucose transport protein 4 (GLUT4) translocation [62, 63], increasing insulin secretion [64].”
Patani, N., Dunbier, A. K., Anderson, H., Ghazoui, Z. F., Ribas, R., Anderson, E., Gao, Q., A’Hern, R., Mackay, A. G., Lindemann, J. P. O., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1378 · Cited by 36
Lappano, R., Mallet, C., Rizzuti, B., Grande, F., Galli, G., Byrne, C., Broutin, I., Boudieu, L., Eschalier, A., Jacquot, Y., et al. (2019) · Cells · doi:10.3390/cells8060590 · Cited by 36 · cited 1×
“…agonist of GPER in SkBr3 breast cancer cells [273], not only by inhibiting GPER-mediated transactivation of EGFR and reducing the phosphorylation of ERK1/2 and c-Fos [274] but also by inducing the ubiquitin-mediated degradation of GPER, thereby decreasing its membrane expression levels [275].”
Ding, X., Gao, T., Gao, P., Meng, Y., Zheng, Y., Dong, L., Luo, P., Zhang, G., Shi, X., & Rong, W. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01351 · Cited by 36 · cited 1×
“Emerging evidence suggests that GPER may indirectly modulate vitamin D metabolism by altering intracellular calcium levels and influencing VDR activity [106, 107].”
Intracellular Glucose‐Depriving Polymer Micelles for Antiglycolytic Cancer Treatment
Lee, J., Kim, K., Kwon, I. C., & Lee, K. Y. (2022) · Advanced Materials · doi:10.1002/adma.202207342 · Cited by 36 · cited 1×
“The “Warburg effect” refers to the phenomenon in which tumor cells enhance glycolytic pathways to obtain energy under hypoxic conditions [228, 229].”
Hippo Signaling: A Stress Response Pathway in Stem Cells
Zeybek, N. D., Baysal, E., Bozdemir, Ö., & Büber, E. (2021) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x16666210712100002 · Cited by 35 · cited 1×
“The MAPK pathway influences critical processes, including growth, differentiation, apoptosis, and oxidative stress responses [48, 49].”
Targeting the G protein-coupled estrogen receptor (GPER) in obesity and diabetes
Sharma, G., & Prossnitz, E. R. (2021) · Endocrine and Metabolic Science · doi:10.1016/j.endmts.2021.100080 · Cited by 34
Chourasia, T. K., Pang, Y., & Thomas, P. (2015) · Biology of Reproduction · doi:10.1095/biolreprod.114.125674 · Cited by 33
Physiopathologie des stéatoses hépatiques métaboliques
Anty, R., & Gual, P. (2019) · La Presse Médicale · doi:10.1016/j.lpm.2019.09.051 · Cited by 33
Du, Z., Gu, Y., Xie, X., Zhang, M., Jiang, G.-Y., & Chen, W. (2021) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2021.105989 · Cited by 33 · cited 1×
“Upon activation, GPER stimulates intracellular signaling cascades, including the PI3K/AKT and MAPK/ERK cascades, which further augment mitochondrial respiratory chain activity and ATP production [218].”
Adu‐Amankwaah, J., Bushi, A., Tan, R., Adekunle, A. O., Adzika, G. K., Noah, M. L. N., Nadeem, I., Adzraku, S. Y., Koda, S., Mprah, R., et al. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04886-6 · Cited by 33 · cited 1×
“Furthermore, GPER reduces endothelial cell inflammation and apoptosis, alleviating vascular injury [194].”
Plant PI-PLC signaling in stress and development
Laxalt, A. M., van Hooren, M., & Munnik, T. (2025) · PLANT PHYSIOLOGY · doi:10.1093/plphys/kiae534 · Cited by 33 · cited 1×
“Moreover, DAG activates protein kinase C (PKC) to regulate metabolic enzymes and downstream signaling [44, 45].”
Nox1 downregulators: A new class of therapeutics
Barton, M., Meyer, M. R., & Prossnitz, E. R. (2019) · Steroids · doi:10.1016/j.steroids.2019.108494 · Cited by 32 · cited 1×
“In atherosclerosis, GPER promotes smooth muscle cell proliferation and migration via the PI3K/AKT pathway [197, 198] and reduces oxidative stress by downregulating Nox1 expression, thereby decreasing reactive oxygen species production [199].”
Parle, E., Tio, S. W., Behre, A., CAREY, J. J., Murphy, C. G., O'Brien, T. F., Curtin, W. A., Kearns, S. R., McCabe, J. P., Coleman, C. M., et al. (2019) · JBMR Plus · doi:10.1002/jbm4.10253 · Cited by 32 · cited 1×
“Osteoporosis is a type of MBD characterized by systemic skeletal deterioration, specifically decreased bone mass and the deterioration of the bone tissue microarchitecture, which can increase the risk of fracture [140].”
DeLeon, C., Wang, H. H., Gunn, J., Wilhelm, M., Cole, A., Arnett, S. D., Wang, D. Q. ‐., & Arnatt, C. K. (2020) · Journal of Lipid Research · doi:10.1194/jlr.ra119000592 · Cited by 32 · cited 1×
“2-Cyclohexyl-4-isopropyl-N-(4-methoxybenzyl) aniline, known as CIMBA, reduces the expression of proinflammatory factors and alleviates cholangitis in cholangiocytes by inhibiting the GPER/ NF-κB pathway [280].”
Central role of hypoxia-inducible factor-1α in metabolic reprogramming of cancer cells: A review
Zhu, B., Cheng, L., Huang, B., Liu, R., & Ren, B. (2024) · Medicine · doi:10.1097/md.0000000000040273 · Cited by 31
Bauzá-Thorbrügge, M., Rodríguez-Cuenca, S., Vidal-Puig, A., Galmés-Pascual, B. M., Sbert-Roig, M., Gianotti, M., Lladó, I., & Proenza, A. M. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2018.09.013 · Cited by 30 · cited 4×
“Furthermore, GPER regulates cellular energy metabolism via the AMPK pathway, which may indirectly influence calcium handling [133].”
InfluentialPan, M., Li, J., Ma, C., Fu, K., Li, Z., & Wang, X. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.04.005 · Cited by 30
Self-citationComputational Approaches for the Discovery of GPER Targeting Compounds
Grande, F., Occhiuzzi, M. A., Lappano, R., Cirillo, F., Guzzi, R., Garofalo, A., Jacquot, Y., Maggiolini, M., & Rizzuti, B. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00517 · Cited by 30 · cited 1×
“This structure enables GPER to interact with diverse endogenous and exogenous ligands, modulating physiological and metabolic processes [15, 16].”
Park, J. S., Lee, G. H., Jin, S. W., Pham, T. H., Thai, T. N., Kim, J. Y., Kim, C. Y., Han, E. H., Hwang, Y. P., Choi, C. Y., et al. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114721 · Cited by 30
Ren, J., Tao, Y., Peng, M., Xiao, Q., Jing, Y., Huang, J., Yang, J., Lin, C., Sun, M., Li, L., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05357-9 · Cited by 30
Li, X., Kuang, W., Qiu, Z., & Zhou, Z. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1226458 · Cited by 30
Çebi, M., & Yilmaz, Y. N. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1445634 · Cited by 30 · cited 1×
“NAFLD, a metabolic disorder characterized by hepatic fat accumulation [163], has emerged as one of the most prevalent liver disorders worldwide, and its incidence has increased sharply in recent years [164].”
Direct and indirect effects of estrogens, androgens and intestinal microbiota on colorectal cancer
Wu, Z., Sun, Y., Huang, W., Jin, Z., You, F., Li, X., & Xiao, C. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1458033 · Cited by 30 · cited 2×
“…increases amino acid metabolism, promoting tumor progression [227, 248], whereas in gastric and colorectal cancer cells, GPER activation inhibits key pathways affecting amino acid metabolism, thereby reducing amino acid metabolic utilization and lowering the metabolic state of tumor cells [236].”
Schüler‐Toprak, S., Skrzypczak, M., Ignatov, T., Ignatov, A., Ortmann, O., & Treeck, O. (2020) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-020-03333-4 · Cited by 29 · cited 1×
“…types of tumor cells: in breast and ovarian cancer cells, GPER activation increases amino acid metabolism, promoting tumor progression [227, 248], whereas in gastric and colorectal cancer cells, GPER activation inhibits key pathways affecting amino acid metabolism, thereby reducing amino…”
GPER: An Estrogen Receptor Key in Metastasis and Tumoral Microenvironments
Tirado-Garibay, A. C., Falcón-Ruiz, E. A., Ochoa‐Zarzosa, A., & López-Meza, J. E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914993 · Cited by 29 · cited 1×
“…provides additional energy and biosynthetic precursors to tumor cells, increasing their metabolic capacity and promoting rapid tumor growth [240]; however, an excessive reliance on fatty acids as an energy source may increase tumor cell sensitivity to specific metabolic inhibitors, thereby…”
He, C., Peng, M., Zeng, X., Dong, H., Sun, Z., Xu, J., Liu, M., Liu, L., Huang, Y., Peng, Z., et al. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.70131 · Cited by 29 · cited 2×
“Specific pharmacological targeting of GPER offers promising clinical applications [6–8].”
Self-citationWu, Q.-C., Tang, X., Dai, Z.-Q., Dai, Y., Xiao, H.-H., & Yao, X. (2019) · Phytomedicine · doi:10.1016/j.phymed.2019.153146 · Cited by 28 · cited 1×
“Experimental data indicate that GPER-specific agonists, exemplified by G1, increase the expression of mineralization markers in osteoblasts, thereby promoting bone formation [111].”
Estradiol/GPER affects the integrity of mammary duct-like structures in vitro
Deng, Y. L., Miki, Y., & Nakanishi, A. (2020) · Scientific Reports · doi:10.1038/s41598-020-57819-9 · Cited by 28 · cited 1×
“Conversely, nonselective GPER agonists, notably 17β-estradiol, activate both GPER and classical estrogen receptors, eliciting multifaceted effects on metabolic conditions [255, 256].”
Wang, Q., Zhao, L., Liu, K., Liu, J., Chai, S., Chen, G., Wen, S., Ming, T., Wang, J., Ma, Y., et al. (2020) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.120.000216 · Cited by 28 · cited 1×
“Inflammatory marker levels are significantly reduced, and tissue inflammation is improved after G1 treatment in animal models [138].”
Self-citationZhang, H., Zhou, H., Shen, X. M., Lin, X., Zhang, Y., Sun, Y., Zhou, Y., Zhang, L., & Zhang, D. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1276707 · Cited by 28 · cited 1×
“In postmenopausal women, GPER overexpression correlates with an increased risk of type 2 diabetes and metabolic syndrome, and GPER antagonists may counteract these adverse metabolic outcomes [278].”
Self-citationGPER-Induced ERK Signaling Decreases Cell Viability of Hepatocellular Carcinoma
Qiu, Y., Xiong, J., Fu, Q., Dong, Y., Liu, M., Peng, M., Jin, W., Zhou, L., Xu, X., Huang, X., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.638171 · Cited by 27 · cited 2×
“Similarly, males with hepatocellular carcinoma present both a higher incidence and more aggressive tumor phenotypes than females do, and female patients with higher GPER activation generally present with smaller tumors and prolonged survival [77].”
Self-citationLi, L., Wang, Y., Wang, H. H., Yang, Y., & Ma, H. (2023) · Journal of Animal Science · doi:10.1093/jas/skad197 · Cited by 27 · cited 1×
“Research has shown that GPER promotes the biosynthesis of fatty acids by regulating the expression of genes associated with fatty acid synthesis [175, 238, 239], providing essential lipid components for tumor cells [238].”
Kurt, A. H., Çelik, A., & KELLECİ, B. M. (2015) · Oncology Letters · doi:10.3892/ol.2015.3711 · Cited by 26 · cited 1×
“These enzymes are pivotal in preserving intracellular redox homeostasis, thereby bolstering cellular resilience to oxidative stress [124].”
Kotula‐Balak, M., Górowska-Wójtowicz, E., Milon, A., Pawlicki, P., Tworzydlo, W., Płachno, B. J., Krakowska, I., Hejmej, A., Wolski, J. K., & Bilińska, B. (2020) · PROTOPLASMA · doi:10.1007/s00709-020-01488-y · Cited by 26
Zanatta, A. P., Brouard, V., Gautier, C., Gonçalves, R., Bouraïma-Lelong, H., Silva, F. R. M. B., & Delalande, C. (2017) · Basic and Clinical Andrology · doi:10.1186/s12610-017-0053-z · Cited by 25
Insufficiency of B vitamins with its possible clinical implications
Tanaka, K., Ao, M., & Kuwabara, A. (2020) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.20-56 · Cited by 25 · cited 1×
“These vitamins act as coenzymes in numerous biochemical reactions, and their deficiencies are associated with health disorders, including metabolic syndromes [128].”
27-Hydroxycholesterol Binds GPER and Induces Progression of Estrogen Receptor-Negative Breast Cancer
Avena, P., Casaburi, I., Zavaglia, L., Nocito, M. C., Padula, D. L., Rago, V., Dong, J., Thomas, P., Mineo, C., Sirianni, R., et al. (2022) · Cancers · doi:10.3390/cancers14061521 · Cited by 25 · cited 1×
“In cancer cells, GPER activation influences the ERK1/2 pathway, promoting the degradation of proliferation-associated proteins [86, 87] and suppressing tumor cell apoptosis.”
Yang, Y., Huangfu, L., Li, H., & Yang, D. (2023) · International Journal of Hyperthermia · doi:10.1080/02656736.2023.2270654 · Cited by 25 · cited 1×
“In tumor cells, certain metabolic processes change due to their survival and proliferation needs, a process known as “tumor metabolic reprogramming“ [223–225].”
Notas, G., Kampa, M., Pelekanou, V., Troullinaki, M., Jacquot, Y., Leclercq, G., & Castanas, E. (2013) · Molecular Oncology · doi:10.1016/j.molonc.2013.02.012 · Cited by 24 · cited 1×
“ERα17p functions as an inverse agonist of GPER in SkBr3 breast cancer cells [273], not only by inhibiting GPER-mediated transactivation of EGFR and reducing the phosphorylation of ERK1/2 and c-Fos [274] but also by inducing the ubiquitin-mediated degradation of GPER, thereby decreasing its membrane…”
Lin, X., Li, L., Wu, S., Tian, J., & Zheng, W. (2019) · IUBMB Life · doi:10.1002/iub.2118 · Cited by 24 · cited 6×
“Additionally, activated GPER may increase glucose and lipid metabolism in osteoblasts, thereby improving the activity and function of bone cells [110, 149, 150].”
InfluentialLachowski, D., Cortés, E., Matellan, C., Rice, A. J., Lee, D. A., Thorpe, S. D., & Hernández, A. E. D. R. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.592628 · Cited by 24
The GPER Agonist LNS8801 Induces Mitotic Arrest and Apoptosis in Uveal Melanoma Cells
Ambrosini, G., Natale, C. A., Musi, E., Garyantes, T. K., & Schwartz, G. K. (2023) · Cancer Research Communications · doi:10.1158/2767-9764.crc-22-0399 · Cited by 24 · cited 2×
“Moreover, G36, another small-molecule antagonist, has shown strong effects on inhibiting the GPER signaling pathway, particularly in studies related to cardiovascular and metabolic diseases, which have documented stronger antagonistic effects [265].”
Cirillo, F., Talia, M., Santolla, M. F., PELLEGRINO, M. A., Scordamaglia, D., Spinelli, A., Rosis, S. D., Giordano, F., Muglia, L., Zicarelli, A., et al. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01654-0 · Cited by 24 · cited 1×
“These transcription factors regulate the expression of GPER target genes, ultimately promoting the apoptosis of cancer cells [69, 70].”
Holm, A., Hellstrand, P., Olde, B., Svensson, D., Leeb-Lundberg, L. M. F., & Nilsson, B. (2013) · Journal of Vascular Research · doi:10.1159/000354252 · Cited by 23
Kampa, M., Pelekanou, V., Gallo, D., Notas, G., Troullinaki, M., Pediaditakis, I., Charalampopoulos, I., Jacquot, Y., Leclercq, G., & Castanas, E. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23309 · Cited by 23
Li, Q., Yang, Y., Wang, H. H., Jiang, Z., & Ma, H. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120676 · Cited by 23 · cited 3×
“It also mediates hepatic glucose output via the AMPK and PI3K/AKT signaling pathways [31, 82].”
Ding, Q., Chorazyczewski, J., Gros, R., Motulsky, H. J., Limbird, L. E., & Feldman, R. D. (2022) · Pharmacology Research & Perspectives · doi:10.1002/prp2.995 · Cited by 23
Dihydrotestosterone induces arterial stiffening in female mice
Horton, A. C., Wilkinson, M. M., Kilanowski‐Doroh, I., Dong, Z., Liu, J., Ogola, B. O., Visniauskas, B., & Lindsey, S. H. (2024) · Biology of Sex Differences · doi:10.1186/s13293-024-00586-3 · Cited by 23
Self-citationWang, J., Li, H., Shen, S.-Y., Zhang, J., Liang, L., Huang, H., Li, B., Wu, G.-C., Zhang, Y., & Yu, J. M. (2020) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2020.105807 · Cited by 22 · cited 1×
“Moreover, the impact of GPER on the cellular energy status extends beyond mitochondrial oxidative phosphorylation, as it modulates various signaling pathways [220].”
Yao, Y., Wang, H., Yang, Y., Jiang, Z., & Ma, H. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120926 · Cited by 22 · cited 1×
“Within these pathways, dehydro-epiandrosterone (DHEA) activates GPER, triggering the AMPK-Nrf2 (nuclear factor erythroid 2-related factor 2) signaling cascade, which enhances the hepatic antioxidant capacity and alleviates oxidative stress [80].”
Mancinelli, C. D., Marx, D. C., Gonzalez-Hernandez, A. J., Huynh, K. W., Mancinelli, L., Arefin, A., Khelashvili, G., Levitz, J., & Eliezer, D. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2407744121 · Cited by 22
Osteoprotective effects of estrogen membrane receptor GPR30 in ovariectomized rats
Kang, W., Deng, Y., Wang, D., Feng, D., Liu, Q., Wang, X., Ru, J., Cong, Y., Zhao, J.-N., Zhao, M., et al. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.07.002 · Cited by 21 · cited 1×
“In addition, GPER regulates intracellular signaling pathways and affects the overall energy metabolism and biosynthesis of bone cells [148].”
Zhu, P., Yuen, J. M. L., Sham, K. W. Y., & Cheng, C. H. K. (2013) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2013.07.004 · Cited by 21 · cited 1×
“Moreover, GPER activation may reduce fat synthesis and promote lipolysis by regulating adipocyte differentiation and function, decreasing visceral fat accumulation [98, 181].”
Aliagan, A. I., Madungwe, N. B., Tombo, N., Feng, Y., & Bopassa, J. C. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.579161 · Cited by 21
Amino Acids in Endoplasmic Reticulum Stress and Redox Signaling
Yang, Y., He, Y., Jin, Y., Wu, G., & Wu, Z. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-74180-8_3 · Cited by 21 · cited 1×
“Efficient amino acid metabolism is critical for sustaining physiological homeostasis [83, 84].”
Estrogen alleviates hepatocyte necroptosis depending on GPER in hepatic ischemia reperfusion injury
Li, Z., Chen, L., Chu, H., Wang, W., & Yang, L. (2021) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-021-00846-5 · Cited by 21 · cited 1×
“In addition, GPER can influence the progression of NAFLD by regulating hepatocyte apoptosis and autophagy, helping to alleviate the cell damage caused by liver inflammation [77, 171].”
Zhang, Y., Song, Y., Ren, S., Zhang, M., Zhang, Z., Fan, S., Liu, X., Peng, X., Qi, Q., Shen, X., et al. (2022) · Oncogene · doi:10.1038/s41388-022-02506-4 · Cited by 21 · cited 2×
“In drug-resistant breast cancer cells, GPER stabilizes the expression of hypoxia-inducible factor 1 alpha (HIF-1α), regulating the glycolytic metabolism of tumor cells and promoting metabolic reprogramming [230].”
Li, L., Yao, Y., Wang, Y., Cao, J., Jiang, Z., Yang, Y., Wang, H. H., & Ma, H. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.105661 · Cited by 21 · cited 1×
“Research has demonstrated that GPER activation regulates hepatic lipid deposition by inhibiting lipogenesis and promoting fatty acid oxidation, thereby reducing hepatic fat accumulation and attenuating inflammatory responses [103, 168].”
Zhang, M., Mao, C., Dai, Y., Xu, X., & Wang, X. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118076 · Cited by 21
Self-citationYong, L., Huang, M., Wei, Y., Xu, J., & Yi, Z. (2020) · Analytical Methods · doi:10.1039/d0ay01052a · Cited by 20 · cited 2×
“…C-terminal region coupled to heterotrimeric G proteins, which mediate downstream signaling cascades excitability, supporting processes such as cardiomyocyte contractility, neuronal synaptic plasticity, and hormone secretion via GPER-mediated signaling, thus influencing energy metabolism [18].”
Frank, A. R., Li, V., Shelton, S. D., Kim, J., Stott, G. M., Neckers, L. Μ., Xie, Y., Williams, N. S., Mishra, P., & McFadden, D. G. (2023) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-0982 · Cited by 20
Kilanowski‐Doroh, I., McNally, A. B., Wong, T. J., Visniauskas, B., Blessinger, S. A., Sugi, A. I., Richard, C., Diaz, Z. T., Horton, A. C., Natale, C. A., et al. (2024) · Hypertension · doi:10.1161/hypertensionaha.123.22024 · Cited by 20 · cited 1×
“Moreover, LNS8801 was found to be more effective than the racemic agonist G1 in reversing rigidity in ovariectomized mice [267].”
Contribution of GPR30 for 1,25 dihydroxyvitamin D3 protection in EAE
Subramanian, S., Miller, L., Grafe, M. R., Vandenbark, A. A., & Offner, H. (2011) · Metabolic Brain Disease · doi:10.1007/s11011-011-9266-6 · Cited by 18
Zang, L., Zhang, Q., Zhou, Y. J., Zhao, Y. P., Lu, L., Zhou, J., Peng, Z., & Zou, S. (2016) · Systems Biology in Reproductive Medicine · doi:10.3109/19396368.2016.1164260 · Cited by 18 · cited 4×
“In recent years, numerous studies have focused on the role of GPER in PCOS, suggesting that GPER plays a significant role in the pathogenesis of this condition [154, 155].”
InfluentialSelf-citationZhang, L., Zhao, Y., & Guo, L. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3470 · Cited by 18 · cited 1×
“Research has demonstrated that GPER activation promotes insulin release via the phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT) pathway and enhances pancreatic β-cell function and survival [73].”
GDF5 Promotes White Adipose Tissue Thermogenesis via p38 MAPK Signaling Pathway
Zhang, W., Wu, X., Zhou, P., Kieß, W., Yang, Y., Xu, Y., Chang, Z., Wu, J., Sun, C., & Luo, F. (2019) · DNA and Cell Biology · doi:10.1089/dna.2019.4724 · Cited by 18 · cited 1×
“…cAMP-response element binding protein; Nrf2, nuclear factor erythroid 2-related factor 2; NF-κB, nuclear factor kappa-light-chain-enhancer of activated B cells; TNF-α, tumor necrosis factor alpha; IL-1β, interleukin-1 beta; IL-6, interleukin-6 insulin sensitivity and adipocyte function [51–53].”
Yao, W., Tao, R., Wang, K., & Ding, X. (2024) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(24)60618-7 · Cited by 18 · cited 2×
“It also modulates eNOS expression and activity, promoting NO production to enhance vascular dilation and hemodynamics [193].”
Li, R., Wang, Y., Chen, P., Meng, J., & Zhang, H. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.30149 · Cited by 17 · cited 1×
“Moreover, GPER activation has been shown to improve retinal structure and function, which can help mitigate visual impairments associated with vitamin A deficiency [117–119], involving the potential mechanism of regulating retinal neuron survival via oxidative damage and apoptosis.”
Alagöz, O., Zhang, Y., Arroyo, N., Fernandes‐Taylor, S., Yang, D., Krebsbach, C., Venkatesh, M., Hsiao, V., Davies, L., & Francis, D. O. (2023) · Value in Health · doi:10.1016/j.jval.2023.12.007 · Cited by 17 · cited 2×
“Specifically, GPER may promote the proliferation of thyroid cancer cells by regulating the expression of cell cycle-related genes [202].”
Chaperones, somatotroph tumors and the cyclic AMP (cAMP)-dependent protein kinase (PKA) pathway
Schernthaner-Reiter, M. H., Trivellin, G., & Stratakis, C. A. (2019) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2019.110607 · Cited by 16
Dinh, Q. N., Vinh, A., Arumugam, T. V., Drummond, G. R., & Sobey, C. G. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15521 · Cited by 16 · cited 1×
“Epidemiological data reveal distinct sex differences in CVD incidence and mortality, with rates notably increasing in women following menopause [187–189].”
Tian, M., Wu, Z., Heng, J., Chen, F., Guan, W., & Zhang, S. (2021) · Nutrition Reviews · doi:10.1093/nutrit/nuab021 · Cited by 16 · cited 1×
“It underpins energy balance and cellular functions, with its dysregulation implicated in numerous metabolic disorders [89–91].”
A phosphoproteomic approach reveals that PKD3 controls PKA-mediated glucose and tyrosine metabolism
Loza‐Valdes, A., Mayer, A. E., Kassouf, T., Viera, J. T., Schmitz, W., Dziaczkowski, F., Leitges, M., Schlösser, A., & Sumara, G. (2021) · Life Science Alliance · doi:10.26508/lsa.202000863 · Cited by 16 · cited 1×
“As a second messenger, cAMP binds the regulatory subunits of the PKA tetramer with two regulatory and two catalytic subunits, releasing and activating the catalytic subunits to regulate cellular metabolism [28– 30].”
MicroRNAs Involved in Oxidative Stress Processes Regulating Physiological and Pathological Responses
Xu, Y., Huang, X., Luo, Q., & Zhang, X. (2021) · MicroRNA · doi:10.2174/2211536610666210716153929 · Cited by 16
Self-citationYao, Y., Wang, H., Yang, Y., Jiang, Z., & Ma, H. (2023) · Molecular Immunology · doi:10.1016/j.molimm.2023.01.008 · Cited by 16 · cited 2×
“By activating the AMPK signaling pathway, GPER promotes the expression of antioxidant enzymes, reduces oxidative stress, and diminishes inflammatory damage to liver cells [170].”
Azizian, H., Farhadi, Z., Bäder, M., Ghalenoei, J. A., Ghafari, M. A., & Mahmoodzadeh, S. (2023) · PLoS ONE · doi:10.1371/journal.pone.0293630 · Cited by 16 · cited 3×
“Additionally, GPER activates AMPK, which improves cellular insulin responses and mitigates insulin resistance [58].”
Mechanisms involved in the regulation of mitochondrial quality control by PGAM5 in heart failure
Wang, Y., Ren, T., Li, C., Wu, Q., Liu, J., Guan, X., Chang, X., Liu, Z., & Liu, R. (2024) · Cell Stress and Chaperones · doi:10.1016/j.cstres.2024.05.004 · Cited by 16 · cited 1×
“This regulatory role is particularly pronounced in disease states such as diabetes and cancer, highlighting the importance of GPER in cellular energy metabolism [219].”
Self-citationGregory, J. G., Hawken, E. R., Angelis, S., Bouchard, J., & Dumont, É. C. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2019.03.030 · Cited by 15 · cited 1×
“GPER is highly expressed in brown adipocytes, and its levels are closely correlated with the functional state of adipose tissue [211, 212].”
Bertoni, A. P. S., Manfroi, P. D. A., Tomedi, J., Brasil, B. A., Meyer, E. L. D. S., & Furlanetto, T. W. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111397 · Cited by 15
Wang, Z., Li, X., Liu, X., Yang, Y., Yan, Y., Cui, D., Meng, C., Ali, M. I., Zhang, J., Yao, Z., et al. (2025) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2025.106701 · Cited by 15 · cited 1×
“Selective compounds such as G1 (a specific agonist) and G15/G36 (specific antagonists) share a quinoline-based structure and have advanced GPER research [24–26].”
Leo, A. D., Jérusalem, G., Torres, R., Verhoeven, D., Pendergrass, K. B., Malorni, L., Lichfield, J., & Martín, M. (2018) · The Breast · doi:10.1016/j.breast.2017.12.016 · Cited by 14
Research works printed but not linked: 9
- Sirizi MAG, Esmailidehaj M, Mohamadi-Zarch SM, et al. Cardioprotective effects of Gper agonist in ovariectomized diabetic rats: reversing Er stress and structural changes. Naunyn Schmiedebergs Arch Pharmacol. 2024. h t t p s : / / d o i . o r g / 1 0 . 1 0 0 7 / s 0 0 2 1 0 -0 2 4 -0 3 4 3 8 -4. · DOI
- Pepermans RA, Sharma G, Prossnitz ER. G protein-coupled estrogen receptor in cancer and stromal cells: functions and novel therapeutic perspectives. Cells. 2021. https://doi.org/10.3390/cells10030672. · DOI
- Gupta A, Shinde PG, Jorvekar S, et al. G protein-coupled oestrogen receptor regulates branched-chain amino acid metabolism through c-jun n-terminal kinase. FEBS Lett. 2025. https://doi.org/10.1002/1873-3468.70030. · DOI
- Cao Y, Zhao LW, Chen ZX, et al. New insights in lipid metabolism: potential therapeutic targets for the treatment of Alzheimer’s disease. Front Neurosci. 2024;18:1430465. https://doi.org/10.3389/fnins.2024.1430465. · DOI · Paper page
- Pawar P, Ma L, Byon CH, et al. Molecular mechanisms of tamoxifen therapy for cholangiocarcinoma: role of calmodulin. Clin Cancer Res. 2009;15(4):1288–96. https://doi.org/10.1158/1078-0432.Ccr-08-1150. · DOI
- Di Leo A, Jerusalem G, Torres R, et al. First-line vs second-line fulvestrant for hormone receptor-positive advanced breast cancer: a post-hoc analysis of the confirm study. Breast. 2018;38:144–9. https://doi.org/10.1016/j.breast.2017.12.016. · DOI
- Lappano R, Santolla MF, Pupo M, et al. Mibe acts as antagonist ligand of both estrogen receptor α and Gper in breast cancer cells. Breast Cancer Res. 2012;14(1): R12. https://doi.org/10.1186/bcr3096. · DOI · Paper page
- Maggiolini M, Santolla MF, Avino S, et al. Identification of two benzopyrroloxazines acting as selective Gper antagonists in breast cancer cells and cancer-associated fibroblasts. Future Med Chem. 2015;7(4):437–48. https://doi.org/10.4155/fmc.15.3. · DOI
- Lappano R, Rosano C, Pisano A, et al. A calixpyrrole derivative acts as an antagonist to gper, a g-protein coupled receptor: mechanisms and models. Dis Model Mech. 2015;8(10):1237–46. https://doi.org/10.1242/dmm.021071. · DOI
Cited by
Lee, A. A., & Den Hartigh, L. J. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1682231 · Cited by 32
Hao, X., Cao, H., Shi, B., Bai, C., Liu, X., & Meng, X. (2026) · iScience · doi:10.1016/j.isci.2026.114890 · Cited by 6
“55 The potential endocrine disrupting effects of BPB and BPAF elevate the risk of ovarian disease, uterine lesions, and breast cancer.”
Targeting GLP1 receptor for reducing global cardiovascular risk
Curcio, A., Meringolo, F., Marincolo, C., Polimeni, A., & Costanzo, S. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-07736-8 · Cited by 2
“It has been demonstrated that G-protein coupled estrogen receptors increase resistance to oxidative damage [52] and exert anti-inflammatory effects by inhibiting the mitogen activated protein kinase (MAPK) pathways [53] reducing cardiac arrhythmias [54].”
Ormiston, K., Shinde, N., Sarathy, G., Zhang, A., Bauer, M., Shukla, R. K., Alsammerai, S., Gupta, A., Bennouna, D., Wesolowski, J., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27041951 · Cited by 2
“Activation of GPER by estrogen has shown to regulate tissue metabolism specifically by increasing oxidative phosphorylation, promoting aerobic glycolysis, and reducing adipocyte hypertrophy [23–25].”
Self-citationMore than alternative estrogen receptors: the emerging role of GPER-1 and ERα36 in breast cancer
Molina, L., Torres, R. F., Spies, J., Meneses, S. S., Soto, M., Carrasco, J., Gálvez, J., Muñoz, D., Soto, J., & Arancibia, Y. (2026) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2026.1002377 · Cited by 2
Metadata
- Authors
- Liu, L., Zhou, Y., Liu, J., Zhang, X., He, C., Zeng, X., Dejenie, R., Zeb, U., Zeng, Q., Liu, L., Li, J., Zeng, X., Hu, Q., Huang, X., Xu, X., Dong, H., Zhong, J., Huang, Y., Lv, Q., Liu, B., Qiu, Y.-A., & Yu, T.
- Affiliations
- Jiangxi Provincial Cancer Hospital (CN)
- Jiangxi University of Traditional Chinese Medicine (CN)
- Nanchang University (CN)
- Nanchang Medical College (CN)
- University of Chicago Medical Center (US)
- The University of Agriculture, Peshawar (PK)
- Corresponding author
- Liu, Bo
- Yu, Tenghua
- ORCID
- Venue
- Journal of Translational Medicine
- Published
- 2025-08-26
- Volume
- 23
- Issue
- 1
- Pages
- 960-960
- ISSN
- 1479-5876 (ISSN-L)
- PMC
- PMC12382220
- OpenAlex
- W4413658314
- Cited by
- 13
- References
- 284
- Citations by year
- 2026: 12 · 2025: 1
- FWCI
- 1.99
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/4.0 (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0 (vor)
- Locations
- Journal of Translational Medicine (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (82160565, 82260565)
- Major Discipline Academic and Technical Leaders Training Program of Jiangxi Province (20232BCJ23035)
- Education Department of Jiangxi Province (GJJ2203532)
- General Project of Jiangxi Provincial Administration of Traditional Chinese Medicine (2023B1281)
- Open Research Fund of Jiangxi Cancer Hospital & Institute (2021J16)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Keywords
- G protein-coupled estrogen receptor, metabolic homeostasis, nutrient metabolism, glucose metabolism, lipid metabolism, protein metabolism, type 2 diabetes, non-alcoholic fatty liver disease, metabolic syndrome, cardiovascular disease, thyroid dysfunction, energy balance, thermogenesis, cancer metabolism, metabolic disease treatment
- MeSH terms
- Animals, Energy Metabolism, Homeostasis, Humans, Metabolic Diseases, Receptors, Estrogen, Signal Transduction, Receptors, G-Protein-Coupled
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.